France FR

Scope of intervention

Sycomore Corporate Finance acted as exclusive financial advisor to IMV Technologies and its management

Date of closing

April 2021

In January 2021, Montagu Private Equity (“Montagu”), a leading European private equity firm, has entered into exclusive negotiations with Qualium Investissement to acquire IMV Technologies (“IMV”), a global leader in animal reproduction biotechnologies.

Based in Normandy, France, IMV Technologies is the world leader in the design, manufacture, distribution and service of equipment and supplies used in animal reproduction and animal reproductive and clinical imaging. Its Life Sciences division features products used in human medical research and assisted reproduction. With operations in France, Brazil, China, India, the Netherlands, Russia, South Africa, the United Kingdom and the United States, and a vast network of distributors across more than 120 countries, IMV Technologies generates more than 85% of its revenue internationally.

Supported by Qualium Investissement, IMV Technologies’ management team has considerably grown the business over the past years through seven acquisitions and continued investments in R&D, which have allowed it to broaden its expertise and strengthen its global leadership in animal artificial insemination.


  • Reinforce IMV’s leadership position in the animal reproduction market
  • Further support IMV’s R&D and innovation strategy, in particular in the animal artificial insemination, thanks to Montagu’s deep expertise in the healthcare and technology sectors
  • Support IMV and its management in their expansion strategy, both in France and internationally

IMV at a glance

IMV Technologies is the world leader in animal assisted reproduction biotechnologies.  Founded in 1963, IMV Technologies, a French company, has subsidiaries and/or manufacturing facilities in Brazil, China, France, India, Italy, the Netherlands, Russia, Scotland, South Africa, and the United States.  IMV Technologies operates leading brands in the areas of semen analysis, assisted reproduction, artificial insemination, and veterinary imaging. IMV Technologies’ Life Sciences division, CryoBio System, manufactures and distributes equipment and supplies for human assisted reproduction and biobanking..

Montagu Private Equity at a glance

Montagu Private Equity is a leading European investment fund investing in mid-market companies with enterprise values comprised between €200 million to €1 billion and revenues comprised between €50 million to €2 billion. It primarily invests alongside management teams in companies based in Europe with a focus on UK, France, Germany and the Nordic region, and across a diversified range of sectors. Montagu is headquartered in London, and has four additional offices in Frankfurt, Paris, Amsterdam, and Warsaw.